SCHEMBL5572994

SCHEMBL5572994

CC(Oc1cccc2ncnc(Nc3ccc(Oc4cnccn4)c(Cl)c3)c12)C(=O)N1CCOCC1

nearest known ligand 0.75

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ERBB2 P04626 19/20 0.75
KCNH2 Q12809 6/20 0.72
EGFR P00533 3/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5635964 1.00 ERBB2 (0.75) ERBB2KCNH2EGFR
SCHEMBL5637823 0.92 ERBB2 (0.76) ERBB2KCNH2EGFR
SCHEMBL5635649 0.92 ERBB2 (0.81) ERBB2KCNH2EGFR
SCHEMBL5636108 0.90 ERBB2 (0.84) ERBB2KCNH2EGFR
SCHEMBL5572891 0.90 ERBB2 (0.84) ERBB2KCNH2EGFR
SCHEMBL5636027 0.86 ERBB2 (0.74) ERBB2KCNH2EGFR
SCHEMBL5570098 0.86 ERBB2 (0.74) ERBB2KCNH2EGFR
SCHEMBL5636514 0.86 ERBB2 (0.73) ERBB2KCNH2EGFR
SCHEMBL5635747 0.86 ERBB2 (0.80) ERBB2KCNH2EGFR
SCHEMBL5572331 0.86 ERBB2 (1.00) ERBB2KCNH2EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1756088-A1 QUINAZOLINE DERIVATIVES AS ERBB RECEPTOR TYROSINE KINASES AstraZeneca AB (SE) 2007-02-28 EP disclosed
WO-2005118572-A1 QUINAZOLINE DERIVATIVES AS ERBB RECEPTOR TYROSINE KINASES ASTRAZENECA AB (SE) 2005-12-15 WO disclosed